Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Contact phone
Neelam Singh, PhD | 517.364.5591
Principal investigator
Dr. Aghiad Chamdin, MD
Trial Category
Childhood Cancers
Trial SubCategory
Leukemia
Webform